In addition, targeting Srm for the treatment of B-cell lymphomas is actively pursued [59] and polyamines have been shown to influence activity of NFκB that was associated with an up-regulation of genes involved in proliferation in breast cancer cells [60]. Here, NFKB1 is linked to B-cell non-Hodgkin lymphoma.